University of Crete (UOC)
Λοιμώδεις επιπλοκές της θεραπείας με φλουνταραμπίνη σε αρρώστους με χρόνια λεμφογενή λευχαιμία
Abstract
dc:descriptionBACKGROUND: PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) ARE AT RISK OF INFECTIOUS MORBIDITY AND MORTALITY.IN EARLY, UNTREATED CLL PATIENTS, THIS RISK MAY BE RELATED TO HYPOGAMMAGLOBULINEMIA, BUT IN PATIENTS WITH ADVANCED DISEASE, PARTICULARLY THOSE TREATED WITH THE NEWER PURINE ANALOGUES, NEUTROPENIA AND DEFECTS IN CELL-MEDIATED IMMUNITY APPEAR TO BE THE MAJOR PREDISPOSING FACTORS. FLUDARABINE, A NOVEL PURINE ANALOGUE WITH MAJOR ACTIVITY IN CLL, HAS RESULTEDIN SERIOUS AND UNUSUAL OPPORTUNISTIC INFECTIONS, ACCORDING TO SOME BRIEF REPORTS. HOWEVER, SYSTEMIC ANALYSIS OF THE OBSERVED FLUDARABINE-ASSOCIATED INFECTIOUS MORBIDITY IS LACKING. THE SCOPE OF THE STUDY WAS TO REVIEW THE CHANGING PATTERN OF INFECTIONS IN PATIENTS WITH CLL TREATED WITH FLUDARABINE. PATIENTS AND METHODS: ALL PATIENTS WITH CLL TREATED WITH FLUDARABINE CARED FOR AT MD ANDERSON CANCER CENTER BETWEEN 1984 AND 1991 WERE ANALYZED RETROSPECTIVELY. PATIENTS WERE INCLUDED IN THE STUDY IF THEY HAD ADVANCED CLL AND HAD RECEIVED A 5 DAY COURSE OF FLUDARABINE (30MG/M2/DAY) WITH OR WITHOUT PREDNISONE (30MG/M2 /DAY) ON A MONTHLY BASIS.THE SIGNIFICANCE OF THEIR FEBRILE EPISODES WASDETERMINED BY RECORDING AND ANALYZING EACH ONE, BY ISOLATION OF THE CAUSATIVE ORGANISM AND EVALUATION OF THE OUTCOME. RESULTS: INFECTIONS OF ALL TYPES OCCURED MORE FREQUENTLY IN PATIENTS PRETREATED WITH CYTOTOXIC CHEMOTHERAPY (47%) THAN IN UNTREATED PATIENTS (24%)(P<.001). THREE HUNDRED EIGHTY-TWO INFECTIOUS EPISODES OCCURED (ABSTRACT TRUNCATED)
Degree
thesis:*- Grantor dc:publisher
- University of Crete (UOC)
- Year dc:date
- 1998
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Kontoyiannis, Dimitrios
- Κοντογιάννης, Δημήτριος
Subjects
dc:subject × 11Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/11333